IIFL Capital Q1: consolidated PAT ā¹184 Cr, up just 5% YoY as revenue growth stalls at 2%
PAT +4.92% YoY Ā· revenue +2.29% Ā· margins flat
ā¹631.48 Cr
+2.29% YoY
ā¹184.16 Cr
+4.92% YoY
25.53%
-0.3pp YoY
ā¹5.92
IIFL Capital Services (formerly IIFL Securities) posted consolidated Q1FY27 (quarter ended June 30, 2026) revenue from operations of ā¹631.48 Cr, up a muted 2.3% YoY from ā¹617.37 Cr, with net profit of ā¹184.16 Cr, up 4.9% YoY from ā¹175.53 Cr. The headline optics are a 60% sequential jump in PAT and a 55% QoQ surge in PBT to ā¹239.28 Cr ā but that reflects a rebound off a weak March quarter (ā¹115.11 Cr PAT) rather than fresh momentum; against the year-ago base the print is broadly flat-to-steady. Net profit margin on total revenue held around 25-26% YoY (the filing's own PAT/revenue-from-operations metric reads 29%), so this was margin preservation, not expansion.
Q1 FY-2027 vs prior quarters
The capital-markets segment did the heavy lifting: segment PBT rose to ā¹236.55 Cr from ā¹223.10 Cr a year ago and ā¹140.68 Cr in Q4, with management flagging retail-equities revenue up 13% YoY and institutional equities/investment banking up 2% YoY; total AUM and custody assets reached ā¹2,571 billion (+12% QoQ). Offsetting this, the insurance-broking segment swung to a ā¹2.56 Cr PBT loss (from a ā¹3.00 Cr profit year-ago) as its revenue fell to ā¹56.62 Cr from ā¹85.54 Cr in Q4. Standalone PAT was ā¹189.01 Cr on ā¹565.39 Cr operating revenue; the two bases tell the same story, so no divergence flag is needed.
The stock went into the print at ā¹335, down 1.4% over the past month of trading.
Management did not provide specific quantitative guidance but expressed confidence that the company is well-capitalized to support approximately 20% growth over the next few years from internal accruals. They plan to focus on expanding the wealth management business by increasing the headcount of wealth RMs and buildin
ā This quarter: missed
On guidance, management offered no formal quarterly numbers on the Q4 concall but voiced confidence in supporting ~20% growth over the next few years from internal accruals ā this quarter's ~5% YoY PAT and ~2% YoY revenue track well below that medium-term ambition, so the pace is a miss for the period even if the multi-year aim is intact. We found no published street consensus for IIFLCAPS this quarter, so the print is judged on our own comparison base. Two corporate items frame the quarter: Fairfax India (via FIH Mauritius) is moving to lift its stake to at least 51%, including a ā¹2,000 Cr preferential issue at ā¹350/share approved at the June 1 EGM ā a capital-base and credibility catalyst ā and the board cleared an up-to-ā¹1,000 Cr NCD enabling resolution. A senior-management reshuffle (two Joint CEOs for Private Wealth, new CTOs) aligns with management's stated push to scale the wealth business. A pending income-tax search demand (ā¹124.37 Cr group-level) sits as a contingent risk with no provision taken.
W1
Whether YoY PAT/revenue growth (~5%/~2% this quarter) can re-accelerate toward management's ~20% medium-term ambition
W2
Insurance-broking recovery ā segment must reverse its ā¹2.56 Cr PBT loss and rebuild from ā¹56.62 Cr revenue
W3
Completion of the Fairfax ā„51% transaction and deployment of the ā¹2,000 Cr preferential-issue capital into wealth/AMC build-out
Consolidated PAT ā¹184.16 Cr is total profit for the period (owners ā¹184.09 Cr, NCI ā¹0.07 Cr), matching our records' netProfit basis. Source in ā¹ Lakhs, converted Ć·100. No exceptional item in P&L. Contingent income-tax search demands (ā¹124.37 Cr consolidated / ā¹68.07 Cr standalone) noted but not provided for. Insurance-broking segment slipped to a ā¹2.56 Cr PBT loss.
Weak growth masked by one-time MTM gains; Fairfax deal pending
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks ā the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Delivered +2.3% revenue YoY vs prior ~20% guidance; operational PBT ā9% YoY before one-time gains; distribution ā14% YoY.
Cautiously Optimistic
next 1ā2 quarters
Optimistic
multi-year
IIFL's +2.3% YoY revenue starkly misses prior ~20% growth guidance. Underlying operations softened: distribution ā14% YoY, operational PBT ā9% YoY. One-time ā¹90 Cr BSE mark-to-market gain masks weak core broking trends. Fairfax's pledged ā¹2,000 Cr capital is the growth lynchpin, but funds not yet received and regulatory approval (2ā3 months) remains uncertain. Execution risk high: minimal RM hiring contradicts stated wealth expansion strategy.
ā¹631.5 Cr
Revenue Ā· +2.3% YoYā¹184.2 Cr
Reported PAT Ā· +4.9% YoYFlat
Margins Ā· vs guidance: OverstatedDid the claims hold up?
Revenue virtually flat year-on-year
OVERSTATEDā¹631.5 Cr delivered; YoY +2.3%, QoQ ā2.0%. Not flat; below prior ~20% guidance.
Retail broking up 13% YoY at ā¹297 Cr
METā¹297 Cr vs ā¹264 Cr in Q1 FY26. Confirmed +13%.
Institutional & IB flat YoY at ā¹207 Cr
METā¹207 Cr vs ā¹204 Cr in Q1 FY26. Confirmed flat.
Distribution down 14% YoY due to Q4 insurance peak
OVERSTATEDā¹125 Cr this quarter; prior year implied ~ā¹145 Cr for -14%. Partially explained by non-recurring factors but yield compression (87 bps) signals structural headwind.
AUM growth one-off; will catch up next quarter
MISSOrganic FPD collections ā¹3,600 Cr this quarter. No concrete plan for acceleration articulated.
Earnings quality
What changed since the last call
Revenue growth sharply decelerated
DowngradePrior ~20% CAGR guidance; Q1 FY27 realized +2.3% YoY. No acknowledgment of miss; deflected with 'catch-up' language.
RM hiring stalled despite wealth strategy
DowngradeSingle-digit RM additions this quarter; organic FPD collections ā¹3,600 Cr (below prior quarter trajectory per management's 'catch-up' comment).
Distribution income structural weakness
Downgradeā¹125 Cr vs likely ~ā¹145 Cr prior year; ā14% YoY. Yield decline to 87 bps signals not just seasonal Q4 insurance peak.
The Q&A
Analysts pressed on AUM slowdown and RM hiring; management gave defensive, vague responses ('single digit,' 'one-off,' 'catch-up'). On distribution yield and RBI regulatory impact, management was clearer but deferred long-term assessment. Did not directly address guidance miss.
AUM growth slowdown ā Keshav Karwa, White Pine IVM Capital
PartialNet collections ā¹3,675 Cr FPD; management says one-off, expects catch-up from next quarter
Fairfax capital readiness ā Keshav Karwa, White Pine IVM Capital
AnsweredFunds not received; awaiting SEBI/NSE/BSE/IRDAI approvals in 2ā3 months; will support growth across capital markets, wealth, asset management, institutional equity
Wealth RM hiring ā Keshav Karwa, White Pine IVM Capital
PartialSingle-digit number
Institutional equity vs IB revenue ā Keshav Karwa, White Pine IVM Capital
PartialInstitutional equities roughly ā¹200 Cr (ballpark); 50ā50 to 60ā40 split with IB
AIF/PMS growth strategy ā Lalit Mohan Deo, Equirus Securities
PartialPart of in-house manufacturing strategy; started AIF, PMS, credit fund, late-stage fund; will invest to grow while maintaining open architecture
RBI margin regulation impact ā Neha, Abakkus Investment Managers
AnsweredMarginal impact so far; company not prop trader; too early to assess full long-term impact
Distribution yield compression ā Neha, Abakkus Investment Managers
AnsweredFPD income fell due to Q4 insurance peak and non-ARR income mix shift; product-wise yield unchanged, mix effect only
IB revenue estimation ā Palash, 360 ONE Capital
PartialRoughly ā¹200 Cr combined; 50ā50 to 60ā40 split (imprecise range)
Guidance
Prior: ~20% CAGR over 'next few years' (from FY26 call)
LowQ1 FY27 delivers +2.3% YoY; missed guidance by wide margin. No new guidance provided; deflected with 'catch-up' and 'one-off' language.
No explicit margin guidance; delivered OPM 35.8%, NPM 25.5%
LowFinance cost pressure (+50% YoY from higher MTF book) and distribution yield compression (87 bps) signal margin headwinds if not offset by capital leverage post-Fairfax.
Fairfax ā¹2,000 Cr capital to support growth across all segments
MediumConditional on regulatory approval (SEBI, NSE, BSE, IRDAI) within 2ā3 months. Will fund wealth RM expansion, AIF/PMS platform scaling, capital markets, institutional equity.
Risks the call surfaced
Deal completion risk
HighFairfax ā¹2,000 Cr preferential investment at ā¹350/share subject to approvals from SEBI, NSE, BSE, IRDAI. Management estimates 2ā3 months; funds not yet received. Regulatory uncertainty could delay or derail capital infusion, capping growth trajectory.
Execution risk in wealth expansion
HighWealth management and RM expansion stated as growth priority. Yet Q1 FY27 added only single-digit RMs. AUM organic collections ā¹3,675 Cr slower than prior trend; management called it 'one-off' but offered no concrete catch-up plan. Risk: capital infusion won't translate to effective RM hiring and AUM growth.
Tax and regulatory risk
HighIT department conducted search under Section 132 in January 2025 and issued demand of ā¹124 Cr to holding company and subsidiaries. Appeal filed but outcome uncertain. If demand upheld, material one-time P&L headwind and potential regulatory scrutiny.
Distribution business structural pressure
HighDistribution income ā¹125 Cr down 14% YoY. Management attributes to Q4 FY26 insurance peak and non-recurring transactional income, but implied yield compression to 87 bps and organic collection slowdown signal underlying headwind. Uncertain if near-term recovery material or if business faces structural competition/margin pressure.
Regulatory headwind from RBI margin rules
MediumRBI margin requirement guidelines effective July 1 aim to reduce leverage in F&O. Management reports marginal impact so far (company not prop trader, limited affected customers), but long-term volume impact uncertain. Turnover down 2% QoQ already; could accelerate if rules tightened further.
Management
Score 6/10. Transparent on deal status (Fairfax approvals in process), tax situation (appeal filed), and regulatory impact (RBI margins marginal so far). But evasive on operational specifics: RM headcount not disclosed exactly, institutional equity vs IB split given as vague range ('50ā50 to 60ā40'). Did not directly address guidance miss vs prior ~20% CAGR. Delivered +2.3% YoY revenue vs prior ~20% guidance; significant miss. Distribution business declining (ā14% YoY). RM additions single digit this quarter despite wealth expansion as stated priority; indicates execution lag vs ambition.
1 Ā· Oct 2026
Fairfax regulatory approval completion and ā¹2,000 Cr capital infusion
2 Ā· Q2āQ3 FY27
Wealth RM scaling and AIF/PMS platform growth after capital infusion
3 Ā· Q3 FY27
Resolution of IT income tax demand (ā¹124 Cr appeal outcome)
Execution risk high: minimal RM hiring contradicts stated wealth expansion strategy.
The ā¹90 Crore Gain That Can't Hide the Miss
Revenue growth collapsed to +2.3% YoY, missing prior ~20% CAGR guidance by a country mile. A ā¹90 crore mark-to-market gain inflates profit; strip it and operations weakened.
ā¹631.5 Cr
+2.3% YoY vs. ā¹617.3 Cr prior year
ā¹184.2 Cr
+4.9% YoY, but driven largely by one-time gains
ā¹90 Cr
other income; non-recurring
~ā¹59 Cr
ā9% YoY; ex-MTM and one-time items
The tension: guidance shattered, results propped up
IIFL Securities delivered ā¹631.5 crore in Q1 FY27 revenue ā a whisper of growth at +2.3% year-on-year. This is not a typo. Prior to this quarter, management had indicated confidence in approximately 20% growth over the next few years from internal accruals and Fairfax partnership. The street expected at least a multi-digit organic beat. What they got was near-flat, a miss so stark that no restatement of strategic optionality can paper over it. The company's reported net profit of ā¹184.2 crore rose 4.9% YoY, which would look steady ā except that ā¹90 crore of the move came from a BSE mark-to-market gain, a one-time security valuation credit unrelated to core broking, distribution, or investment banking. Strip that, and operational profit before tax would be roughly ā¹59 crore, down 9% from the prior year.
Management's claims vs. what held up
Revenue 'virtually flat' ā claimed near-stability
Retail broking up 13% YoY to ā¹297 Cr ā core franchise holding strong
Distribution income down 14% YoY, blamed on Q4 insurance peak ā partial
AUM organic collections 'one-off' slowdown, to catch up next quarter ā unsubstantiated
RM additions in single digits; wealth 'expansion priority' ā acute execution lag
The most striking gap was on RM (relationship manager) hiring. When asked how many wealth managers were added in Q1, management responded 'single digit' ā twice ā without a firm number. For a company claiming wealth management and in-house platform building as the growth lever post-Fairfax, adding fewer than ten RMs in a full quarter reads as stalled, not strategic patience. Organic FPD (Financial Product Distribution) collections of ā¹3,600 crore likewise slowed vs. prior-quarter trajectory, contradicting management's 'catch-up' framing.
Distribution: structural headwind, not seasonal
Distribution income fell to ā¹125 crore, down 14% from roughly ā¹145 crore in the prior year. Management attributed this to Q4 FY26 carrying non-recurring insurance income and high transactional revenue; a seasonal reversion was expected. But the implied yield also compressed to 87 basis points, the lowest cited in the analysis, signaling that the business mix is shifting unfavorably ā not just the Q4 calendar effect. This matters because distribution (mutual funds, insurance, AIF/PMS) is IIFL's second-largest profit centre and a pillar of the Fairfax investment thesis. Yield compression + organic collection slowdown suggest competitive intensity or product mix headwinds that may persist.
ā¹297 Cr
+13% YoY; ADT ā¹3.16 lakh Cr (ā2% QoQ)
ā¹207 Cr
flat YoY; no traction vs. retail strength
ā¹125 Cr
ā14% YoY; yield 87 bps (structural decline)
ā¹60 Cr
+50% YoY due to enlarged margin trading book
What changed on this call
Three material shifts from prior commentary:
Prior ~20% multi-year CAGR guidance vs. delivered +2.3% YoY ā no new guidance offered
Wealth RM additions single digit vs. management's stated expansion mandate
Distribution business structural yield compression (87 bps) + organic collection slowdown
The Fairfax partnership remains the company's redemption story. The ā¹2,000 crore preferential investment at ā¹350 per share is not yet received; regulatory approvals from SEBI, NSE, BSE, and IRDAI are pending and expected within 2ā3 months. This capital is earmarked to accelerate wealth management, AIF/PMS platform scaling, capital markets, and institutional equity. But until funds arrive and deployment plans crystallize, it remains a forward option, not a present catalyst.
How the street read this
The market's initial reaction was lukewarm. On day 1 post-announcement, the stock barely moved (ā0.06%), delivery-weighted at 67.2%. By day 3, it had slipped to ā0.75%, and by day 5 to ā1.22%, suggesting the initial neutrality gave way to disappointment as investors parsed the guidance miss and one-time gain weighting. This fading pop is the street's own verdict: the quarter looked better on headlines than substance.
ā¹338
ā17.78% from ā¹411.1 all-time high
ā¹338
+39.47% off ā¹242.35
RSI 51.4
neutral; below SMA20 (ā¹338.07) and SMA50 (ā¹340.22); above SMA200 (ā¹326.65)
At ā¹338, the stock is down 17.8% from its all-time high of ā¹411.1, a notable drawdown. Foreign institutional investors (FII) have been quietly trimming: ownership fell from 17.24% in Q1 FY26 to 16.33% by Q4 FY26, a steady 91 basis point slide. This is not a panic, but a systematic walk toward the exits by offshore money. Domestic institutional investors (DII) have added marginally (+18 bps QoQ to 5.57%), and promoters are stable at 30.87%. The pattern suggests FIIs are being spooked by the execution risk (Fairfax deal uncertainty, RM hiring lag) and the margin/growth deceleration, while domestic players remain patient but not accumulating aggressively.
The debate
Bull
positiveRetail broking +13% YoY; franchise intact
Bull
positiveFairfax ā¹2,000 Cr capital structurally transformative IF deployed
Bull
positiveFortress margins (OPM 35.8%, NPM 25.5%); balance sheet strong
Bear
negativeGuidance miss severe: +2.3% YoY vs. prior ~20% CAGR; not acknowledged
Bear
negativeOperational profit ā9% YoY ex-gains; core business in decline
Bear
negativeDistribution ā14% YoY; yield compression (87 bps) signals structural headwind
Bear
negativeRM hiring single digit per quarter; execution lag vs. stated strategy
Bear
negativeFairfax capital not yet received; regulatory approvals uncertain (2ā3 months)
Bear
negativeFinance cost +50% YoY due to leverage; margin pressure if rates elevated
Bear
negativeIT income tax demand ā¹124 Cr under appeal; legal uncertainty
Risks, ranked by holder concern
1
High
ā¹2,000 Cr capital infusion is the lynchpin of the growth thesis. Funds not yet received; SEBI, NSE, BSE, IRDAI approvals pending in 2ā3 months (not guaranteed). Delay or rejection would cap near-term upside sharply and force IIFL into organic-only mode with decelerating trends.
Fairfax deal regulatory uncertainty and timing
2
High
Wealth management is stated as the post-Fairfax growth driver, yet single-digit RM additions this quarter suggest staffing lag or execution paralysis. If RM hiring does not accelerate materially post-Fairfax, capital deployment will be constrained and the wealth thesis will fizzle. Organic AUM collection slowdown (ā¹3,600 Cr this quarter) adds to concern.
Execution risk in RM and wealth scaling
3
High
Down 14% YoY; yield compressed to 87 bps (lowest in analysis). Management blamed Q4 insurance peak, but organic collection slowdown and yield deterioration suggest headwinds are more structural (competition, product mix, regulatory pressure). If this is a durable headwind, IIFL's second-largest profit centre will erode margins.
Distribution business structural decline
4
High
ā¹124 Cr demand issued to holding company and subsidiaries in January 2025; appeal filed but outcome uncertain. If upheld, material one-time P&L hit and potential reputational/regulatory scrutiny. Resolution expected Q3 FY27.
IT income tax demand and appeal outcome
5
Medium
Finance cost jumped 50% YoY to ā¹60 Cr due to enlarged margin trading finance (MTF) book. If rates remain elevated or trading leverage increases further, margin compression will accelerate. RBI margin requirement guidelines (effective July 1) may also constrain F&O volumes and MTF demand.
Finance cost leverage and rate sensitivity
6
Medium
RBI rules effective July 1 aim to reduce F&O leverage. IIFL reports marginal near-term impact (not a prop trader; limited affected customers), but long-term volume impact uncertain. ADT already down 2% QoQ to ā¹3.16 lakh Cr; if rules tighten further, broking volumes could erode.
RBI margin requirement regulation (F&O leverage)
What to watch next
1 Ā· Fairfax regulatory approval announcement (expected within 2ā3 months)
Any update on SEBI, NSE, BSE, or IRDAI approvals will be a major re-rating event. Approval = growth visibility restored; delay/rejection = significant downside for the stock. This is binary and high-stakes.
2 Ā· Q2 FY27 organic run-rate (RM hiring, AUM collections, distribution yield)
Without an MTM cushion, Q2 will expose whether the core business can accelerate. Watch for: (a) RM additions vs. Q1's single-digit pace; (b) organic FPD collections vs. Q1's ā¹3,600 Cr; (c) distribution yield stabilization vs. the 87 bps low. If RM hiring remains single digit and collections flat, the Fairfax capital thesis fails.
3 Ā· IT income tax appeal outcome (Q3 FY27 expected)
ā¹124 Cr demand under appeal; unfavorable verdict would be a material one-time P&L hit and regulatory overhang. A favourable outcome or settlement removes a risk.
4 Ā· Institutional broking and IB revenue momentum (vs. flat Q1)
This segment is ā¹207 Cr combined (roughly 50ā50 to 60ā40 split between equities and IB per management), flat YoY. Retail broking strength (+13%) is not yet lifting institutional; watch for reacceleration or continued lag. Persistent flatness signals market-share loss.
The number to track from here
Strip out the ā¹90 crore mark-to-market gain and focus on organic operational PBT. In Q1 FY27, that was roughly ā¹59 crore, down 9% from the prior year. This is the health of the franchise. If Q2 operational PBT stabilizes or grows, management has a credible catch-up narrative. If it stays flat or declines further, the guidance miss and execution lag are no longer temporary ā they are structural.
IIFL Securities is a steady, well-capitalized business with a strong retail broking franchise. But this quarter revealed cracks in the growth narrative: prior ~20% multi-year guidance has evaporated, core operations are weakening (distribution ā14% YoY, operational PBT ā9% YoY), and execution on the stated wealth expansion strategy is stalled (single-digit RM hires). The reported profit beat was an optical trick ā ā¹90 crore of one-time gain from a mark-to-market security valuation.
The Fairfax deal is the reset button. ā¹2,000 crore of capital, if deployed, could unlock the wealth and asset-management upside management envisions. But regulatory approval is not certain, and funds are not yet in hand. Until September, this is a forward option, not a present catalyst. Holders should demand clarity on RM hiring plans and distribution stabilization ā not vague 'catch-up' language ā before buying the Fairfax story.
Rating: Hold. Valuation at 17.8% drawdown from ATH and trading neutral technicals reflects fair risk-reward for a company in mid-pivot. The next 60 days (Fairfax approval) and Q2 earnings (organic run-rate proof) will decide whether this is a reset or a step-down. FII selling (ā91 bps over four quarters) is a warning flag; domestic money is not yet convinced the story is re-rating.